Caspase-8 is a caspase protein, encoded by the CASP8 gene. It most likely acts upon caspase-3. CASP8orthologs have been identified in numerous mammals for which complete genome data are available. These unique orthologs are also present in birds.
The CASP8 gene encodes a member of the cysteine-aspartic acidprotease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined.
A very rare genetic disorder of the immune system can also be caused by mutations in this gene. This disease, called CEDS, stands for “Caspase eight deficiency state.” It is characterized by splenomegaly and lymphadenopathy, in addition to recurrent sinopulmonary infections, recurrent mucocutaneous herpesvirus or other viral infections, and hypogammaglobulinemia.
^Chun H, Zheng L, Ahmad M, Wang J, Speirs C, Siegel R et al. (2002). "Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency". Nature419 (6905): 395–9. doi:10.1038/nature01063. PMID12353035.
^ abcdefGajate C, Mollinedo F (March 2005). "Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy". J. Biol. Chem.280 (12): 11641–7. doi:10.1074/jbc.M411781200. PMID15659383.
^ abcdefghGuo Y, Srinivasula S, Druilhe A, Fernandes-Alnemri T, Alnemri E (April 2002). "Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria". J. Biol. Chem.277 (16): 13430–7. doi:10.1074/jbc.M108029200. PMID11832478.
^Poulaki V, Mitsiades N, Romero M, Tsokos M (June 2001). "Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2". Cancer Res.61 (12): 4864–72. PMID11406564.
^Goltsev Y, Kovalenko A, Arnold E, Varfolomeev E, Brodianskii V, Wallach D (August 1997). "CASH, a novel caspase homologue with death effector domains". J. Biol. Chem.272 (32): 19641–4. doi:10.1074/jbc.272.32.19641. PMID9289491.
^ abSrinivasula S, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y et al. (July 1997). "FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis". J. Biol. Chem.272 (30): 18542–5. doi:10.1074/jbc.272.30.18542. PMID9228018.
^Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson D et al. (November 2002). "The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex". J. Biol. Chem.277 (47): 45162–71. doi:10.1074/jbc.M206882200. PMID12215447.
^Roth W, Stenner-Liewen F, Pawlowski K, Godzik A, Reed J (March 2002). "Identification and characterization of DEDD2, a death effector domain-containing protein". J. Biol. Chem.277 (9): 7501–8. doi:10.1074/jbc.M110749200. PMID11741985.
^Cowling V, Downward J (October 2002). "Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain". Cell Death Differ.9 (10): 1046–56. doi:10.1038/sj.cdd.4401065. PMID12232792.
^Zhan Y, Hegde R, Srinivasula S, Fernandes-Alnemri T, Alnemri E (April 2002). "Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC". Cell Death Differ.9 (4): 439–47. doi:10.1038/sj/cdd/4401038. PMID11965497.
^Henshall D, Araki T, Schindler C, Shinoda S, Lan J, Simon R (September 2003). "Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures". J. Neurochem.86 (5): 1260–70. doi:10.1046/j.1471-4159.2003.01934.x. PMID12911633.
^Boldin M, Goncharov T, Goltsev Y, Wallach D (June 1996). "Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death". Cell85 (6): 803–15. doi:10.1016/s0092-8674(00)81265-9. PMID8681376.
^Thomas L, Stillman D, Thorburn A (September 2002). "Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen". J. Biol. Chem.277 (37): 34343–8. doi:10.1074/jbc.M204169200. PMID12107169.
^ abMacFarlane M, Ahmad M, Srinivasula S, Fernandes-Alnemri T, Cohen G, Alnemri E (October 1997). "Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL". J. Biol. Chem.272 (41): 25417–20. doi:10.1074/jbc.272.41.25417. PMID9325248.
^Gervais F, Singaraja R, Xanthoudakis S, Gutekunst C, Leavitt B, Metzler M et al. (February 2002). "Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi". Nat. Cell Biol.4 (2): 95–105. doi:10.1038/ncb735. PMID11788820.
^Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B et al. (October 1999). "Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis". J. Neurosci.19 (19): 8244–51. PMID10493725.
^Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalò P, Oriente F et al. (August 1999). "PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis". Oncogene18 (31): 4409–15. doi:10.1038/sj.onc.1202831. PMID10442631.
^Chaudhary P, Eby M, Jasmin A, Kumar A, Liu L, Hood L (September 2000). "Activation of the NF-kappaB pathway by caspase 8 and its homologs". Oncogene19 (39): 4451–60. doi:10.1038/sj.onc.1203812. PMID11002417.
^Bertrand M, Milutinovic S, Dickson K, Ho W, Boudreault A, Durkin J et al. (June 2008). "cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination". Mol. Cell30 (6): 689–700. doi:10.1016/j.molcel.2008.05.014. PMID18570872.
^Leo E, Deveraux Q, Buchholtz C, Welsh K, Matsuzawa S, Stennicke H et al. (March 2001). "TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis". J. Biol. Chem.276 (11): 8087–93. doi:10.1074/jbc.M009450200. PMID11098060.
Jia S, Parodo J, Kapus A, Rotstein O, Marshall J (2008). "Dynamic Regulation of Neutrophil Survival through Tyrosine Phosphorylation or Dephosphorylation of Caspase-8". Journal of Biological Chemistry283 (9): 5402–5413. doi:10.1074/jbc.M706462200. PMID18086677.
Gupta S (2002). "Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules". Exp. Gerontol.37 (2–3): 293–9. doi:10.1016/S0531-5565(01)00195-4. PMID11772515.
Zhao L, Zhu H (2005). "Structure and function of HIV-1 auxiliary regulatory protein Vpr: novel clues to drug design". Curr. Drug Targets Immune Endocr. Metabol. Disord.4 (4): 265–75. doi:10.2174/1568008043339668. PMID15578977.